Page 2582 - Hematology_ Basic Principles and Practice ( PDFDrive )

2303.e2 Part XIII Consultative Hematology

51. Kurtzhals JA, Adabayeri V, Goka BQ, et al: Low plasma concentrations prevention of severe anaemia and malaria in Tanzanian infants. Lancet
of interleukin 10 in severe malarial anaemia compared with cerebral and 350:844, 1997.
uncomplicated malaria. Lancet 351:1768, 1998. 74. Schellenberg D, Menendez C, Kahigwa E, et al: Intermittent treat-
52. Othoro C, Lal AA, Nahlen B, et al: A low interleukin-10 tumor necrosis ment for malaria and anaemia control at time of routine vaccinations
factor-alpha ratio is associated with malaria anemia in children residing in Tanzanian infants: a randomised, placebo-controlled trial. Lancet
in a holoendemic malaria region in western Kenya. J Infect Dis 179:279, 357:1471, 2001.
1999. 75. Neuberger A, Okebe J, Yahav D, et al: Oral iron supplements for
53. Zamai L, Secchiero P, Pierpaoli S, et al: TNF-related apoptosis-inducing children in malaria-endemic areas. Cochrane Database Syst Rev
ligand (TRAIL) as a negative regulator of normal human erythropoiesis. (2):CD006589, 2016.
Blood 95:3716, 2000. 76. Drakesmith H, Prentice AM: Hepcidin and the iron-infection axis.
54. de Mast Q, van Dongen-Lases EC, Swinkels DW, et al: Mild increases Science 338:768–772, 2012.
in serum hepcidin and interleukin-6 concentrations impair iron 77. Marsh K, Forster D, Waruiru C, et al: Indicators of life-threatening
incorporation in hemoglobin during an experimental human malaria malaria in African children. N Engl J Med 332:1399, 1995.
infection. Br J Haematol 145:657, 2009. 78. Snow RW, Omumbo JA, Lowe B, et al: Relation between severe malaria
55. Howard CT, McKakpo US, Quakyi IA, et al: Relationship of hepcidin morbidity in children and level of Plasmodium falciparum transmission
with parasitemia and anemia among patients with uncomplicated in Africa. Lancet 349:1650, 1997.
Plasmodium falciparum malaria in Ghana. Am J Trop Med Hyg 77:623, 79. Krishna S, Waller DW, ter Kuile F, et al: Lactic acidosis and hypoglycae-
2007. mia in children with severe malaria: pathophysiological and prognostic
56. Portugal S, Carret C, Recker M, et al: Host-mediated regulation of significance. Trans R Soc Trop Med Hyg 88:67, 1994.
superinfection in malaria. Nat Med 17:732, 2011. 80. English M, Waruiru C, Marsh K: Transfusion for respiratory distress
57. Clark MA, Goheen MM, Fulford A, et al: Host iron status and iron in life-threatening childhood malaria. Am J Trop Med Hyg 55:525,
supplementation mediate susceptibility to erythrocytic stage Plasmo- 1996.
dium falciparum. Nat Commun 5:4446, 2014. 81. Maitland K, Kiguli S, Opoka RO, et al: Mortality after fluid bolus in
58. Perkins DJ, Weinberg JB, Kremsner PG: Reduced interleukin-12 and African children with severe infection. N Engl J Med 364:2483, 2011.
transforming growth factor-β1 in severe childhood malaria: relationship 82. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al: B-type natri-
of cytokine balance with disease severity. J Infect Dis 182:988, 2000. uretic peptide and plasma hemoglobin levels following transfusion of
59. Askenase MH, Han SJ, Byrd AL, et al: Bone-marrow-resident NK cells shorter-storage versus longer-storage red blood cells: results from the
prime monocytes for regulatory function during infection. Immunity TOTAL randomized trial. Am Heart J 183:129, 2017.
42:1130–1142, 2015. 83. Price R, van Vugt M, Phaipun L, et al: Adverse effects in patients with
60. Schwarzer E, Turrini F, Ulliers D, et al: Impairment of macrophage acute falciparum malaria treated with artemisinin derivatives. Am J Trop
functions after ingestion of Plasmodium falciparum-infected erythro- Med Hyg 60:547, 1999.
cytes or isolated malarial pigment. J Exp Med 176:1033, 1992. 84. Molyneux ME, Taylor TE, Wirima JJ, et al: Clinical features and
61. Schwarzer E, Turrini F, Giribaldi G, et al: Phagocytosis of P. falciparum prognostic indicators in paediatric cerebral malaria: a study of 131
malarial pigment hemozoin by human monocytes inactivates monocyte comatose Malawian children. Q J Med 71:441, 1989.
protein kinase C. Biochim Biophys Acta 1181:51, 1993. 85. Ladhani S, Lowe B, Cole AO, et al: Changes in white blood cells and
62. Schwarzer E, Muller O, Arese P, et al: Increased levels of 4-hydroxynonenal platelets in children with falciparum malaria: relationship to disease
in human monocytes fed with malarial pigment hemozoin: a possible outcome. Br J Haematol 119:839, 2002.
clue for hemozoin toxicity. FEBS Lett 388:119, 1996. 86. Abdalla SH: Peripheral blood and bone marrow leucocytes in Gambian
63. Fiori PL, Rappelli P, Mirkarimi SN, et al: Reduced microbicidal and children with malaria: numerical changes and evaluation of phagocyto-
anti-tumour activities of human monocytes after ingestion of Plasmo- sis. Ann Trop Paediatr 8:250, 1988.
dium falciparum-infected red blood cells. Parasite Immunol 15:647, 87. Amodu OK, Adeyemo AA, Olumese PE, et al: Intraleucocytic malaria
1993. pigment and clinical severity of malaria in children. Trans R Soc Trop
64. Pichyangkul S, Saengkrai P, Webster HK: Plasmodium falciparum Med Hyg 92:54, 1998.
pigment induces monocytes to release high levels of tumor necrosis 88. Lyke KE, Diallo DA, Dicko A, et al: Association of intraleukocytic
factor-alpha and interleukin-1β. Am J Trop Med Hyg 51:430, 1994. Plasmodium falciparum malaria pigment with disease severity, clinical
65. Sherry BA, Alava G, Tracey KJ, et al: Malaria-specific metabolite manifestations, and prognosis in severe malaria. Am J Trop Med Hyg
hemozoin mediates the release of several potent endogenous pyrogens 69:253, 2003.
(TNF, MIP-1α, and MIP-1β) in vitro, and altered thermoregulation 89. Kelton JG, Keystone J, Moore J, et al: Immune-mediated thrombocy-
in vivo. J Inflamm 45:85, 1995. topenia of malaria. J Clin Invest 71:832, 1983.
66. Schwarzer E, Ludwig P, Valente E, et al: 15(S)-hydroxyeicosatetraenoic 90. Lampah DA, Yeo TW, Malloy M, et al: Severe malarial thrombocy-
acid (15-HETE), a product of arachidonic acid peroxidation, is an topenia: a risk factor for mortality in Papua, Indonesia. J Infect Dis
active component of hemozoin toxicity to monocytes. Parassitologia 211:623–634, 2015.
41:199, 1999. 91. Grau GE, Mackenzie CD, Carr RA, et al: Platelet accumulation
67. Skorokhod OA, Caione L, Marrocco T, et al: Inhibition of erythro- in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis
poiesis in malaria anemia: role of hemozoin and hemozoin-generated 187:461, 2003.
4-hydroxynonenal. Blood 116:4328, 2010. 92. Pain A, Ferguson DJ, Kai O, et al: Platelet-mediated clumping of
68. Lamikanra AA, Merryweather-Clarke AT, Tipping AJ, et al: Distinct Plasmodium falciparum-infected erythrocytes is a common adhesive
mechanisms of inadequate erythropoiesis induced by tumor necrosis phenotype and is associated with severe malaria. Proc Natl Acad Sci
factor alpha or malarial pigment. PLoS ONE 10:e0119836, 2015. USA 98:1805, 2001.
69. Berkley J, Mwarumba S, Bramham K, et al: Bacteraemia complicating 93. Casals-Pascual C, Kai O, Newton CR, et al: Thrombocytopenia in
severe malaria in children. Trans R Soc Trop Med Hyg 93:283, 1999. falciparum malaria is associated with high concentrations of IL-10. Am
70. Yeats J, Daley H, Hardie D: Parvovirus B19 infection does not contrib- J Trop Med Hyg 75:434, 2006.
ute significantly to severe anaemia in children with malaria in Malawi. 94. MacPherson GG, Warrell MJ, White NJ, et al: Human cerebral
Eur J Haematol 63:276, 1999. malaria: a quantitative ultrastructural analysis of parasitized erythrocyte
71. Brewster DR, Greenwood BM: Seasonal variation of paediatric diseases sequestration. Am J Pathol 119:385, 1985.
in the Gambia, west Africa. Ann Trop Paediatr 13:133, 1993. 95. Holst FG, Hemmer CJ, Foth C, et al: Low levels of fibrin-stabilizing
72. Dicko A, Klion AD, Thera MA, et al: The etiology of severe anemia in factor (factor XIII) in human Plasmodium falciparum malaria: correla-
a village and a periurban area in Mali. Blood 104:1198, 2004. tion with clinical severity. Am J Trop Med Hyg 60:99, 1999.
73. Menendez C, Kahigwa E, Hirt R, et al: Randomised placebo-controlled 96. López JA: Malignant malaria and microangiopathies: merging mecha-
trial of iron supplementation and malaria chemoprophylaxis for nisms. Blood 115:1317, 2010.